Table 4 Distribution of examiners at baseline and follow-up by treatment group
From: Clinical outcomes of Single-Visit oral Prophylaxis: A practice-based randomised controlled trial
Characteristic | 6-month Group N (%) | 12-month Group N (%) | 24-month Group N (%) | Statistical Analysis |
|---|---|---|---|---|
Baseline and Follow-up both examiner 1 | 28 (26.2) | 25 (25.0) | 27 (27.0) | Χ2 test P = 0.995 |
Baseline and Follow-up both examiner 2 | 10 (9.3) | 9 (9.0) | 10 (10.0) | Â |
Baseline examiner 1; Follow-up examiner 2 | 69 (64.5) | 66 (66.0) | 63 (63.0) | Â |